Format

Send to

Choose Destination
See comment in PubMed Commons below
Clin Gastroenterol Hepatol. 2013 Jul 23. pii: S1542-3565(13)01042-2. doi: 10.1016/j.cgh.2013.04.051. [Epub ahead of print]

WITHDRAWN: Dual Therapy With Infliximab and Immunomodulator Reduces 1-Year Rates of Hospitalization and Surgery Among Veterans With Inflammatory Bowel Disease.

Author information

1
Section of Digestive Diseases; Houston VA Health Services Research and Development Center of Excellence, Michael E. DeBakey Veterans Affairs Medical Center, Division of Gastroenterology and Hepatology, Baylor College of Medicine, Houston, Texas. Electronic address: abraham.neena@mayo.edu.

Abstract

The Publisher regrets that this article is an accidental duplication of an article that has already been published, http://dx.doi.org/10.1016/j.cgh.2013.06.004. The duplicate article has therefore been withdrawn.

PMID:
23891919
DOI:
10.1016/j.cgh.2013.04.051
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center